Moreover, real‐time PCR results showed that PAX5 expression was down‐regulated in 83% (19/23) of primary NSCLC tumour tissues compared with their corresponding adjacent tissues (P < 0.0001, Fig. 1B). The gene discussed is PAX5; the disease is non-small cell lung carcinoma.